相关实验视频
Updated: Mar 31, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.4K
一种对抗肥胖的徒劳方法?
Shannon M Reilly1, Alan R Saltiel1
1Department of Medicine, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
Cell
|October 27, 2015
概括
研究人员发现了一种新的分子途径, 这一发现为打击肥胖流行病提供了一个新的目标, 通过增加能量消耗来促进减肥.
科学领域:
- 代谢研究
- 肥胖研究
- 细胞生物学
背景情况:
- 全球肥胖流行需要了解能量平衡机制.
- 能量消耗受基础代谢,体力活动和适应性热生成的影响.
- 针对热生成是一个潜在的体重管理策略.
研究的目的:
- 确定调节热生成的新型分子途径.
- 探索肥胖症的新疗法.
主要方法:
- 研究脂肪细胞中热生成的分子机制.
- 使用细胞和分子生物学技术.
- 专注于发现以前未知的途径.
主要成果:
- 描述了一个新的热生成分子路径.
- 证明了一个控制脂肪细胞能量消耗的新机制.
- 确定了一个调节热生成的潜在目标.
结论:
- 这项研究揭示了一个对热生成至关重要的新分子途径.
- 这一发现为开发抗肥胖策略开辟了道路.
- 准这种途径可能会增加能源消耗,促进体重减轻.
相关概念视频
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients
341
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
341
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
381
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
381
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
283
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
283
Atherosclerosis III: Management
582
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
582
Binge Eating Disorders
757
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
757

